Form D · Biotechnology
TRACT Therapeutics, Inc.
Chicago, IL · CIK 0001772729
Offering snapshot reported Apr 3, 2019 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 18, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 3, 2019 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-336378
Source: Form D, filed Apr 3, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Courossi | Director, Executive |
| Gretchen Johnson | Director, Executive |
| Joseph Leventhal | Director |
| Norbert Riedel | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
125 W. Oak Street, Suite D
Chicago, IL, 60610
Chicago, IL, 60610